Literature DB >> 34729642

The effect of methylphenidate and mixed amphetamine salts on cognitive reflection: a field study.

Eldad Yechiam1, Dana Zeif2.   

Abstract

RATIONALE: Methylphenidate (MPH) and mixed D,L-amphetamine salts (MASs; Adderall) were previously found to have unreliable effects on judgment and decision processes.
OBJECTIVE: We predicted that MPH and MASs have a specific effect of reducing heuristic responses, which should lead to increased performance on the cognitive reflection test (CRT). The CRT is considered to be a testbed for heuristic versus deliberative response modes.
METHODS: We recruited a sample of 15,361 individuals using the Prolific Academic crowdsourcing platform. From this initial pool, our final sample consisted of 294 participants (125 MPH users and 169 MASs users) who conformed to the study criteria and completed the experimental tasks. Tasks were performed on days where participants were either medicated or not, allowing to assess the effect of medication status.
RESULTS: There was a strong positive effect of taking MPH on CRT scores (Cohen's d = 0.40) which was not qualified by frequency of MPH usage, ADHD symptoms, and demographic factors. There was also a somewhat weaker effect for MASs (Cohen's d = 0.07). No effects of MPH and MASs were recorded for risk-taking and numeracy.
CONCLUSIONS: The results indicate that MPH enhances decision-making in tasks where heuristic responses typically bias it.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  ADHD; Amphetamine; Decision-making; Heuristics; Methylphenidate

Mesh:

Substances:

Year:  2021        PMID: 34729642     DOI: 10.1007/s00213-021-06016-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Two Is Not Always Better Than One: A Critical Evaluation of Two-System Theories.

Authors:  Gideon Keren; Yaacov Schul
Journal:  Perspect Psychol Sci       Date:  2009-11

2.  A Theory of Unconscious Thought.

Authors:  Ap Dijksterhuis; Loran F Nordgren
Journal:  Perspect Psychol Sci       Date:  2006-06

3.  Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults.

Authors:  Nirit Agay; Eldad Yechiam; Ziv Carmel; Yechiel Levkovitz
Journal:  Psychopharmacology (Berl)       Date:  2010-04-28       Impact factor: 4.530

4.  The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population.

Authors:  Ronald C Kessler; Lenard Adler; Minnie Ames; Olga Demler; Steve Faraone; Eva Hiripi; Mary J Howes; Robert Jin; Kristina Secnik; Thomas Spencer; T Bedirhan Ustun; Ellen E Walters
Journal:  Psychol Med       Date:  2005-02       Impact factor: 7.723

5.  Trends of outpatient prescription drug utilization in US children, 2002-2010.

Authors:  Grace Chai; Laura Governale; Ann W McMahon; James Phillip Trinidad; Judy Staffa; Dianne Murphy
Journal:  Pediatrics       Date:  2012-06-18       Impact factor: 7.124

6.  Insensitivity to future consequences following damage to human prefrontal cortex.

Authors:  A Bechara; A R Damasio; H Damasio; S W Anderson
Journal:  Cognition       Date:  1994 Apr-Jun

7.  Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder.

Authors:  Adam R Aron; Jonathon H Dowson; Barbara J Sahakian; Trevor W Robbins
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

8.  Is the Type 1/Type 2 Distinction Important for Behavioral Policy?

Authors:  Nick Chater
Journal:  Trends Cogn Sci       Date:  2018-05       Impact factor: 20.229

9.  Determinants of judgment and decision making quality: the interplay between information processing style and situational factors.

Authors:  Shahar Ayal; Zohar Rusou; Dan Zakay; Guy Hochman
Journal:  Front Psychol       Date:  2015-07-30

10.  The 10-year trend in drug prescriptions for attention-deficit/hyperactivity disorder (ADHD) in Germany.

Authors:  Thomas Grimmsmann; Wolfgang Himmel
Journal:  Eur J Clin Pharmacol       Date:  2020-08-17       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.